Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04402710
Other study ID # E2020:006
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2020
Est. completion date February 2, 2021

Study information

Verified date March 2020
Source University of Manitoba
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators plan to examine the feasibility and acceptability of an online, two arm intervention ([self-compassion intervention + ideal care] versus [health information + ideal care]) designed to increase physical activity among individuals at risk of type two diabetes. The aim of the self-compassion intervention is to teach people at risk of type two diabetes how to use self-compassion (orientation to care for oneself during difficult situations) in order to help them self-manage and increase their physical activity. In a group, online format people at risk for type 2 diabetes will learn about their type 2 diabetes risk and strategies to increase their physical activity, which represents the recommended information that people at risk for type two diabetes should receive (i.e. ideal care). In addition to this, some participants, but not all, will be taught to be self-compassionate in relation to their type two diabetes risk and their efforts to increase their physical activity (i.e. intervention group). The other participants (i.e. control group) will instead receive general health information in addition to ideal care. Feasibility outcomes will be assessed using Thabane and colleagues (2010) model including the study's process, resources, management and scientific outcomes. In addition, qualitative exit-interviews with participants and research personnel will be conducted to assess the acceptability and feasibility of the intervention. Lastly, investigators will explore whether the intervention leads to changes from pre- to post-intervention in the secondary outcomes. This study is important as it will help inform and ensure the larger efficacy trial is of high quality.


Description:

The primary research objective of this study is to test the feasibility and acceptability of an online, two arm ([self-compassion intervention + ideal care] versus [health information + ideal care]) intervention designed to increase physical activity among individuals at risk for type 2 diabetes. Primary research question: Is an online, two-arm intervention ([self-compassion intervention + ideal care] versus [health information + ideal care]) focused on increasing physical activity levels among individuals at risk of type two diabetes feasible using Thabane and colleagues model of feasibility (2010)? Secondary research question: Is an online, two-arm intervention ([self-compassion intervention + ideal care] versus [health information + ideal care]) focused on increasing physical activity levels among individuals at risk of type two diabetes acceptable to both participants and research personnel? The secondary research objective is to explore whether an online, two-arm intervention ([self-compassion intervention + ideal care] versus [health information + ideal care]) focused on increasing physical activity levels among individuals at risk of type two diabetes leads to changes from pre- to post-intervention in self-compassion, physical activity levels, nutrition, self-regulatory skill use, experience of exercise barriers, personal growth initiative, negative affect, and engagement in other health behaviours (e.g. stress management). This pilot and feasibility study is a single centre, randomized, active controlled, six week intervention with baseline and follow-up assessment at intervention-end, 6- and 12-weeks post-intervention. It follows a quantitative-dominant, mixed-methods design. They will supplement this trial with interviews after follow-up testing with participants and study personnel. These interviews will provide feasibility and acceptability information.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date February 2, 2021
Est. primary completion date November 10, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years to 74 Years
Eligibility Inclusion Criteria: - Medium to high type 2 diabetes risk (assessed with the CANRISK tool) - Age 40 - 74 - No current medical treatment for type 2 diabetes - Safe to engage in physical activity - No non-study self-reported current type 2 diabetes/behaviour change education that may interfere with the intervention - Available for all sessions and testing - Insufficient physical activity relative to guidelines of 150 minutes of moderate to vigorous physical activity per week. - Below the mean on the self-compassion scale Exclusion Criteria: - Be under 40 years old, or over the age of 74 - Have a medical condition which would not allow them to participate safely in physical activity - Already are part of a different behavioural change/ type 2 diabetes education group - Already engage in over 150 minutes of moderate to vigorous physical activity per week - Already have high levels of self-compassion (over the mean) - Could not commit to the intervention/control sessions

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Self-compassion
Six week behavioural change program plus a self-compassion intervention aimed to increase physical activity among individuals with prediabetes
Control Group
Six week behavioural change program aimed to increase physical activity plus information on general health topics.

Locations

Country Name City State
Canada University of Manitoba Winnipeg Manitoba

Sponsors (2)

Lead Sponsor Collaborator
University of Manitoba Canadian Institutes of Health Research (CIHR)

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recruitment Rate Number of participants screened/showed interest in partaking in the study during the recruitment period and how many of these individuals get successfully recruited into the study. During the recruitment phase of the study
Primary Most successful Recruitment Strategy Participants will be asked to state how they heard about the study During the recruitment phase of the study
Primary Retention Rates The number of people who begin the study relative to the number of people who drop out at any point during the study. Week 1 (baseline) to Week 18 (follow-up)
Primary Compliance This will consist of online class attendance and through participant responses using a text messaging system (e.g. responding 'yes' or 'no' to whether they completed their at home practice), and will be determined by the number of individuals who wear their accelerometer for the recommended 4 days, 10 hours per day. Week 1 (baseline) to Week 18 (follow-up)
Primary Instructor Fidelity How well facilitators conduct class sessions and activities compared to the set protocol. This will be determined by a checklist with a protocol for each session where facilitators will identify what components they did/did not complete and whether they followed the session protocol accordingly. With participant approval, facilitators will video record 15% of all sessions and the principal investigator will assess the adherence to the planned intervention, presentation skills, and will assess the adherence to the planned intervention, presentation skills, and will rate communication skills. The principal investigator will rate each component on a 5-point Likert scale. Week 1 (baseline) to Week 6 (end of intervention)
Primary Capacity This will be determined by evaluating whether the number of hours it takes study personnel to complete study tasks stays under the total cost that was budgeted for personnel hours for this study. Week 1 (baseline) to Week 18 (follow-up)
Primary Process Time How much time it takes to send out the initial eligibility email questionnaire, determine the participant's eligibility, and contact the eligible participant for the next steps of the study. During the recruitment phase of the study
Primary Study Personnel Challenges and Insights Through a semi-structured exit-interview study personnel will be asked whether they encountered any challenges throughout the study or have any reccomendations. 6 weeks (end of intervention)
Primary Participant safety will be assessed by asking participants to explain their thoughts and feelings about whether the study impacted their physical and psychological safety through a semi-structured exit interview. To determine whether participants felt safe while participating in this study, they will be asked to explain their thoughts and feelings through a semi-structured exit-interview. A sample question is, "Did you feel safe physically and psychologically during each session" 6-weeks (end of intervention)
Primary Acceptability as assessed by semi-structured exit interviews with participants which will include questions related to their thoughts and feelings about the study and whether they believed the study was acceptable (e.g. content, timing). To assess participant satisfaction and their experience with the study, they will be asked a variety of questions to understand their thoughts and feelings during the semi-structured exit-interview. An example question participants will be asked is, "what components of the intervention did you like/dislike?" 6 weeks (end of intervention)
Secondary Change in Moderate to Vigorous Physical Activity from baseline to 6 weeks (intervention end) Physical activity as measured by GT3X+ accelerometers (1952 - >9498 counts per min) baseline to 6 weeks (intervention end)
Secondary Change in self-report Moderate to Vigorous Physical Activity from baseline to 6 weeks (intervention end) Physical activity as measured by GT3X+ accelerometers (1952 - >9498 counts per min) baseline to 6 weeks (intervention end)
Secondary Change in Self-Compassion from baseline to 6 weeks (intervention end) Self-Compassion Scale (Neff, 2003); 6-point Likert scale ranging from a mean value of 1 (low self-compassion) to 5 (high self-compassion) baseline to 6 weeks
Secondary Change in Mild Physical Activity from baseline to 6 weeks (intervention end) Measured by GT3X Accelerometers (100 - 1952 counts per min) baseline to 6 weeks (intervention end)
Secondary Change in Sporadic Physical Activity from baseline to 6 weeks (intervention end) Measured by GT3X Accelerometers (bouts of moderate to vigorous physical activity less than 10 minutes with no drop in intensity) baseline to 6 weeks (intervention end)
Secondary Change in Negative Affect Related to Diabetes Risk from baseline to 6 weeks (intervention end) Negative Affect Scale (Leary, Tate, Adams, Allen, & Hancock, 2007); 7-point Likert scale ranging from 1 (not at all) to 7 (Extremely); Scale Range: 20 (low Negative Affect) - 140 (high Negative Affect) baseline to 6-weeks (intervention end)
Secondary Change in Negative Affect Related to Low Physical Activity Levels from baseline to 6 weeks (intervention end) Negative Affect Scale (Leary, Tate, Adams, Allen, & Hancock, 2007); 7-point Likert scale ranging from 1 (not at all) to 7 (Extremely); Scale Range: 20 (low Negative Affect) - 140 (high Negative Affect) 6-weeks (intervention end)
Secondary Change in Health Promoting Behaviors from baseline to 6 weeks (intervention end) Health-Promoting Lifestyle Profile II (Walker, Sechrist, & Pender, 1995); 4-point Likert scale ranging from 1 (never) to 4 (routinely); Scale range: 52 (low engagement in health behaviours) to 208 (high engagement in health behaviours) baseline to 6 weeks (intervention end)
Secondary Change in Fear of Self-Compassion from baseline to 6 weeks (intervention end) Fear of Self-compassion Scale (Gilbert et al., 2011); 5-point Likert scale ranging from 0 (not fearful) - 60 (very fearful) baseline week 1
Secondary Change in Exercise barriers from baseline to 6 weeks (intervention end) Exercise Barrier Scale (Sechrist et al., 1987). 4-point Likert scale ranging from 1 (strongly agree) to 4 (strongly disagree); 14 items; participants are asked to indicate the degree to which they have different barriers to exercise. Higher scores indicate less exercise barriers. Overall score ranges from 14 to 56. baseline to 6 weeks (intervention end).
Secondary Change in Cognitive Emotion Regulation strategies from baseline to 6 weeks (intervention end) Cognitive Emotion Regulation Questionnaire (Garnefski et al. 2001). 5-point Likert scale ranging from 1 (almost never) to 5 (almost always); 36 items; Participants are asked the extent to which they make use of certain cognitive coping strategies. Nine different subscales: self-blame, other-blame, rumination, catastrophizing, putting into perspective, positive refocusing, positive reappraisal, acceptance, refocus on planning. Each subscale is totaled with higher scores indicating higher use of that cognitive emotional strategy. Scores for each subscale can range from 4 to 20. baseline to 6 weeks (intervention end)
See also
  Status Clinical Trial Phase
Recruiting NCT05354245 - Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL) N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT06115265 - Ketogenic Diet and Diabetes Demonstration Project N/A
Completed NCT03188263 - Morning Light Treatment to Improve Glucose Metabolism N/A
Recruiting NCT03821961 - 18F-FDOPA PET/CT Imaging in Patients Undergoing Metabolic Surgery N/A
Completed NCT04303468 - Intervention With a GABA Supplement in Prediabetics N/A
Recruiting NCT06094231 - Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study N/A
Completed NCT03675360 - Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial N/A
Completed NCT01910051 - Explorative Assessment of Biomarkers in Overweight and Obese Subjects
Completed NCT03527368 - The Time-Restricted Intake of Meals Study N/A
Not yet recruiting NCT06453278 - (DDS) in India: a Screening Tool to Identify Prediabetes and Undiagnosed Type 2 Diabetes in Dental Settings
Completed NCT03865342 - Prevention of Diabetes Using Mobile-enabled, Virtual Delivery of the National Diabetes Prevention Program N/A
Completed NCT02899390 - Diabetes Prevention Program in Adults of the Yaqui Tribe of Hermosillo, Sonora at Risk of Diabetes N/A
Suspended NCT03240978 - Exercise Intervention for the Prevention of Prediabetes in Overweight Chinese N/A
Recruiting NCT01972113 - Vitamin K and Glucose Metabolism in Children at Risk for Diabetes (Vita-K 'n' Kids Study) N/A
Completed NCT01436916 - Oral Cholecalciferol in Prevention of Type 2 Diabetes Mellitus Phase 4
Completed NCT01432509 - Prospective Follow-up of a Cohort of Pre-diabetics in the North of France (DiabeNord) N/A
Completed NCT00990184 - Study to Evaluate the Effects of Colesevelam on Insulin Sensitivity and ß-Cell Function in Subjects With Impaired Fasting Glucose (Prediabetes) Phase 3
Completed NCT00886340 - A Lifestyle Change Program to Prevent Type 2 Diabetes Phase 2